Experimental studies of mitochondrial function in CADASIL vascular smooth muscle cells

Experimental Cell Research

Volumn 319, Issue 3, 2013, Pages 134-143

  Viitanen, Matti ^a,b   Sundström, Erik ^a   Baumann, Marc ^c   Poyhonen, Minna ^d   Tikka, Saara ^c   Behbahani, Homira ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

CADASIL; Mitochondrial connectivity; Mitochondrial membrane potential; NOTCH3.; Proliferation; VSMC

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; REACTIVE OXYGEN METABOLITE;

ARTICLE; CADASIL; CELL FUNCTION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; ELECTRON MICROSCOPY; GENE MUTATION; HETEROZYGOTE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INTRACELLULAR MEMBRANE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION FUNCTION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; TOXICITY; TRANSMISSION ELECTRON MICROSCOPY; VASCULAR SMOOTH MUSCLE CELL;

EID: 84872417409     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2012.09.015     Document Type: Article

References (36)

1. Gray F., Polivka M., Viswanathan A., Baudrimont M., Bousser M.G., Chabriat H. Apoptosis in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy. J. Neuropathol. Exp. Neurol. 2007, 66:597-607.
2. Ruchoux M.M., Chabriat H., Bousser M.G., Baudrimont M., Tournier-Lasserve E. Presence of ultrastructural arterial lesions in muscle and skin vessels of patients with CADASIL. Stroke 1994, 25:2291-2292.
3. Schroder J.M., Sellhaus B., Jorg J. Identification of the characteristic vascular changes in a sural nerve biopsy of a case with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Acta Neuropathol. 1995, 89:116-121.
4. Joutel A. Pathogenesis of CADASIL: transgenic and knock-out mice to probe function and dysfunction of the mutated gene, Notch3, in the cerebrovasculature. Bioessays 2010, 33:73-80.
5. Joutel A., Vahedi K., Corpechot C., Troesch A., Chabriat H., Vayssiere C., Cruaud C., Maciazek J., Weissenbach J., Bousser M.G., Bach J.F., Tournier-Lasserve E. Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet 1997, 350:1511-1515.
6. Sweeney C., Morrow D., Birney Y.A., Coyle S., Hennessy C., Scheller A., Cummins P.M., Walls D., Redmond E.M., Cahill P.A. Notch 1 and 3 receptor signaling modulates vascular smooth muscle cell growth, apoptosis, and migration via a CBF-1/RBP-Jk dependent pathway. FASEB J. 2004, 18:1421-1423.
7. Wang W., Prince C.Z., Mou Y., Pollman M.J. Notch3 signaling in vascular smooth muscle cells induces c-FLIP expression via ERK/MAPK activation Resistance to Fas ligand-induced apoptosis. J. Biol. Chem. 2002, 277:21723-21729.
8. Joutel A., Monet M., Domenga V., Riant F., Tournier-Lasserve E. Pathogenic mutations associated with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy differently affect Jagged1 binding and Notch3 activity via the RBP/JK signaling Pathway. Am. J. Hum. Genet. 2004, 74:338-347.
9. Karlstrom H., Beatus P., Dannaeus K., Chapman G., Lendahl U., Lundkvist J., CADASI A. L-mutated Notch 3 receptor exhibits impaired intracellular trafficking and maturation but normal ligand-induced signaling. Proc. Nat. Acad. Sci. USA 2002, 99:17119-17124.
10. Peters N., Opherk C., Zacherle S., Capell A., Gempel P., Dichgans M. CADASIL-associated Notch3 mutations have differential effects both on ligand binding and ligand-induced Notch3 receptor signaling through RBP-Jk. Exp. Cell Res. 2004, 299:454-464.
11. de la Pena P., Bornstein B., del Hoyo P., Fernandez-Moreno M.A., Martin M.A., Campos Y., Gomez-Escalonilla C., Molina J.A., Cabello A., Arenas J., Garesse R. Mitochondrial dysfunction associated with a mutation in the Notch3 gene in a CADASIL family. Neurology 2001, 57:1235-1238.
12. Dotti M.T., De Stefano N., Bianchi S., Malandrini A., Battisti C., Cardaioli E., Federico A. A novel NOTCH3 frameshift deletion and mitochondrial abnormalities in a patient with CADASI. Arch. Neurol. 2004, 61:942-945.
13. Malandrini A., Albani F., Palmeri S., Fattapposta F., Gambelli S., Berti G., Bracco A., Tammaro A., Calzavara S., Villanova M., Ferrari M., Rossi A., Carrera P. Asymptomatic cores and paracrystalline mitochondrial inclusions in CADASIL. Neurology 2002, 59:617-620.
14. Annunen-Rasila J., Finnila S., Mykkanen K., Moilanen J.S., Veijola J., Poyhonen M., Viitanen M., Kalimo H., Majamaa K., Mitochondrial D.N.A. sequence variation and mutation rate in patients with CADASIL. Neurogenetics 2006, 7:185-194.
15. Annunen-Rasila J., Karppa M., Finnila S., Yla-Outinen H., Veijola J., Tuominen H., Peltonen J., Majamaa K. Cytoskeletal structure in cells harboring two mutations: R133C in NOTCH3 and 5650G>A in mitochondrial DNA. Mitochondrion 2007, 7:96-100.
16. Ihalainen S., Soliymani R., Iivanainen E., Mykkanen K., Sainio A., Poyhonen M., Elenius K., Jarvelainen H., Viitanen M., Kalimo H., Baumann M. Proteome analysis of cultivated vascular smooth muscle cells from a CADASIL patient. Mol. Med. 2007, 13:305-314.
17. Gimbrone M.A., Cotran R.S. Human vascular smooth muscle in culture growth and ultrastructure. Lab. Invest. 1975, 33:16-27.
18. Gimbrone M.A., Cotran R.S., Folkman J. Human vascular endothelial cells in culture. Growth and DNA synthesis. J. Cell Biol. 1974, 60:673-684.
19. Elhassan A.M., Adem A., Hultenby K., Lindgren J.U. Somatostatin immunoreactivity in bone and joint tissues. Neuroreport 1998, 9:2573-2575.
20. Sodersten F., Ekman S., Eloranta M.L., Heinegard D., Dudhia J., Hultenby K. Ultrastructural immunolocalization of cartilage oligomeric matrix protein (COMP) in relation to collagen fibrils in the equine tendon. Matrix Biol. 2005, 24:376-385.
21. Weibel E. Stereological methods: practical methods for biological morphometry 1979, Vol 1. Academic, London.
22. Behbahani H., Pavlov P.F., Wiehager B., Nishimura T., Winblad B., Ankarcrona M. Association of Omi/HtrA2 with gamma-secretase in mitochondria. Neurochem. Int. 2010, 57:668-675.
23. Nigg E.A. Cyclin-dependent protein kinases: key regulators of the eukaryotic cell cycle. Bioessays 1995, 17:471-480.
24. Finnila S., Tuisku S., Herva R., Majamaa K. A novel mitochondrial DNA mutation and a mutation in the Notch3 gene in a patient with myopathy and CADASIL. J. Mol. Med. (Berl) 2001, 79:641-647.
25. Tikka S., Mykkanen K., Ruchoux M.M., Bergholm R., Junna M., Poyhonen M., Yki-Jarvinen H., Joutel A., Viitanen M., Baumann M., Kalimo H. Congruence between NOTCH3 mutations and GOM in 131 CADASIL patients. Brain 2009, 132:933-939.
26. Takahashi K., Adachi K., Yoshizaki K., Kunimoto S., Kalaria R.N., Watanabe A. Mutations in NOTCH3 cause the formation and retention of aggregates in the endoplasmic reticulum, leading to impaired cell proliferation. Hum. Mol. Genet. 2010, 19:79-89.
27. Burton D.G., Sheerin A.N., Ostler E.L., Smith K., Giles P.J., Lowe J., Rhys-Williams W., Kipling D.G., Faragher R.G. Cyclin D1 overexpression permits the reproducible detection of senescent human vascular smooth muscle cells. Ann. NY Acad. Sci. 2007, 1119:20-31.
28. Cohen B., Shimizu M., Izrailit J., Ng N.F., Buchman Y., Pan J.G., Dering J., Reedijk M. Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer. Breast Cancer Res. Treat. 2010, 123:113-124.
29. Fasanaro P., Magenta A., Zaccagnini G., Cicchillitti L., Fucile S., Eusebi F., Biglioli P., Capogrossi M.C., Martelli F. Cyclin D1 degradation enhances endothelial cell survival upon oxidative stress. FASEB J. 2006, 20:1242-1244.
30. Green D.R., Reed J.C. Mitochondria and apoptosis. Science 1998, 281:1309-1312.
31. Dagda R.K., Chu C.T. Mitochondrial quality control: insights on how Parkinson's disease related genes PINK1, parkin, and Omi/HtrA2 interact to maintain mitochondrial homeostasis. J. Bioenerg. Biomembr. 2009, 41:473-479.
32. Twig G., Hyde B., Shirihai O.S. Mitochondrial fusion, fission and autophagy as a quality control axis: the bioenergetic view. Biochim. Biophys. Acta 2008, 1777:1092-1097.
33. Xu K., Yang Y., Yan M., Zhan J., Fu X., Zheng X. Autophagy plays a protective role in free cholesterol overload-induced death of smooth muscle cells. J. Lipid Res. 2010, 51:2581-2590.
34. Huang T.T., Yasunami M., Carlson E.J., Gillespie A.M., Reaume A.G., Hoffman E.K., Chan P.H., Scott R.W., Epstein C.J. Superoxide-mediated cytotoxicity in superoxide dismutase-deficient fetal fibroblasts. Arch. Biochem. Biophys. 1997, 344:424-432.
35. Haglund K., Di Fiore P.P., Dikic I. Distinct monoubiquitin signals in receptor endocytosis. Trends Biochem. Sci. 2003, 28:598-603.
36. Joutel A., Andreux F., Gaulis S., Domenga V., Cecillon M., Battail N., Piga N., Chapon F., Godfrain C., Tournier-Lasserve E. The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J. Clin. Invest. 2000, 105:597-605.